Lancet HIV
Scope & Guideline
Empowering researchers and practitioners in the fight against HIV.
Introduction
Aims and Scopes
- HIV Prevention Strategies:
The journal emphasizes innovative approaches in HIV prevention, including pre-exposure prophylaxis (PrEP), harm reduction strategies, and community-based interventions to enhance access and uptake. - Antiretroviral Therapy (ART) Research:
It publishes studies examining the efficacy, safety, and adherence to various antiretroviral regimens, including long-acting formulations and their impacts on treatment outcomes. - Epidemiology and Public Health:
Research on HIV epidemiology, including incidence, prevalence, and the social determinants affecting different populations, is a core focus, informing public health interventions. - Intersectionality and Health Equity:
The journal addresses the intersection of HIV with issues of gender, sexuality, race, and socioeconomic status, advocating for health equity and tailored interventions for marginalized groups. - Global and Regional Responses:
It discusses the global and regional policy responses to HIV, including funding, legislation, and community mobilization efforts, highlighting the importance of advocacy in HIV care.
Trending and Emerging
- Long-Acting Antiretroviral Therapies:
Research on long-acting formulations of antiretroviral therapies is gaining traction, reflecting a movement towards improving adherence and treatment outcomes among people living with HIV. - Health Equity and Social Determinants:
There is an increasing focus on health equity, particularly how social determinants such as race, gender, and socioeconomic status impact HIV outcomes and access to care. - Integration of Mental Health Services:
Emerging studies emphasize the integration of mental health care within HIV treatment protocols, addressing the psychological aspects of living with HIV. - Community-Based and Decentralized Care Models:
The journal highlights innovative community-based models of care that improve access and retention in HIV services, particularly in resource-limited settings. - Impact of COVID-19 on HIV Services:
Research examining the interplay between the COVID-19 pandemic and HIV care has become increasingly relevant, focusing on disruptions in services and adaptations to maintain care.
Declining or Waning
- Traditional HIV Risk Factors:
Research on traditional risk factors for HIV transmission, such as injection drug use and unprotected sex, has decreased as newer studies focus on behavioral interventions and social determinants. - Standalone HIV Treatment Studies:
There has been a noticeable reduction in standalone studies focusing solely on the pharmacokinetics of specific antiretroviral drugs, as more emphasis is placed on integrated treatment approaches and patient-centered care. - Acquired Immunodeficiency Syndrome (AIDS) Terminology:
The use of the term AIDS in research has diminished as the understanding of HIV as a manageable chronic condition has increased, leading to a shift towards more descriptive language. - HIV Criminalization Studies:
Research specifically addressing the legal aspects of HIV criminalization has waned, possibly due to evolving societal attitudes and legal reforms in various regions. - Single Population Studies:
There is a decreasing trend in studies focusing exclusively on single populations, with a growing emphasis on cross-population comparisons to address the global nature of the HIV epidemic.
Similar Journals
CURRENT HIV RESEARCH
Illuminating Innovations in HIV ScienceCurrent HIV Research is a pivotal journal dedicated to the latest advancements in the field of HIV research, published by Bentham Science Publishers Ltd. With a commitment to disseminating high-quality research, this journal serves as a critical resource for researchers, healthcare professionals, and students interested in infectious diseases and virology. The journal has an ISSN of 1570-162X and an E-ISSN of 1873-4251, reflecting its commitment to contemporary digital scholarship. Given its publication history spanning from 2003 to 2024, the journal has continually provided insights and peer-reviewed articles that foster knowledge and innovation in HIV research. Although it currently holds a Q3 ranking in Infectious Diseases and a Q4 ranking in Virology, these rankings underscore its importance as an emerging platform for critical research dialogue. Despite not being an Open Access journal, 'Current HIV Research' ensures that cutting-edge studies reach relevant practitioners and contribute to ongoing discourse in the medical community. By fostering an informed approach to HIV and its implications, this journal is an invaluable asset to those committed to advancing their expertise in this crucial area of health science.
Infectious Agents and Cancer
Exploring the vital links between pathogens and cancer progression.Infectious Agents and Cancer is a pivotal open access journal published by BMC, dedicated to advancing research at the intersection of infectious diseases and oncology. Since its inception in 2006, this journal has provided a platform for the exploration of the complex relationships between infectious agents and cancer development, aimed at researchers, healthcare professionals, and students alike. With a broad scope encompassing epidemiology and cancer research, the journal holds an impressive ranking in the Q3 quadrant for epidemiology, infectious diseases, and oncology in 2023, while also featuring in the Q4 category for cancer research. This distinguished journal not only contributes to the enrichment of scientific knowledge but also fosters collaborative efforts towards innovative solutions in the fight against cancer. Being part of the UK publishing landscape, the journal is accessible to a global audience, ensuring that vital research findings are disseminated widely to inform policy and practice in health sciences.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV
Fostering Informed Solutions for HIV/AIDS ChallengesAIDS CARE - Psychological and Socio-Medical Aspects of AIDS/HIV, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital interdisciplinary platform for researchers, clinicians, and policymakers exploring the complex psychological and socio-medical dimensions of HIV/AIDS. With an ISSN of 0954-0121 and an E-ISSN of 1360-0451, this esteemed journal has been disseminating significant research since 1989 and continues to uphold a commendable reputation in the field, achieving a Q2 ranking in esteemed categories such as Health (Social Science), Public Health, and Social Psychology as per 2023 metrics. Its commitment to enhancing understanding of HIV/AIDS through quantitative and qualitative research makes it essential for stakeholders engaged in health strategies and mental health interventions. While currently not offering open access, the journal provides access to a wealth of authoritative articles that contribute meaningfully to the ongoing discourse surrounding HIV/AIDS and its socio-psychological ramifications. Researchers and students aiming to deepen their knowledge and intervention strategies will find this journal an invaluable resource.
HIV MEDICINE
Transforming Insights into Action Against HIVHIV Medicine is a prestigious journal published by Wiley that stands at the forefront of research in the fields of health policy, infectious diseases, and pharmacology, with a commendable impact factor reflected in its Q1 rankings for 2023. Established in 1999 and set to converge its expertise through 2024, this journal plays a critical role in advancing the understanding and treatment of HIV and related health challenges. It is esteemed for its rigorous peer-review process and its contributions to both clinical and policy-oriented discussions surrounding HIV medicine. With a broad international readership, it serves as a vital resource for researchers, healthcare professionals, and students committed to fighting the global HIV epidemic. Although not open access, its vital insights are indispensable for anyone involved in infectious disease research and healthcare policy. Articles published in HIV Medicine shape global health strategies and influence the future of HIV research, making it a must-read for those dedicated to this crucial field.
AIDS Research and Treatment
Empowering research, enhancing treatment.AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.
Tropical Medicine and Health
Advancing knowledge for healthier tropical communities.Tropical Medicine and Health is a prestigious open-access journal published by BMC that serves as a vital platform for researchers and health professionals focusing on the fields of tropical medicine, infectious diseases, and public health. With an ISSN of 1348-8945 and an E-ISSN of 1349-4147, the journal has established itself in the academic community since its inception in 2004, bridging the gap between research and real-world applications in managing tropical diseases. Recognized for its quality, it holds a commendable Q2 ranking in both the Infectious Diseases and Public Health, Environmental and Occupational Health categories, positioned in the 2023 Scopus rankings within the 85th and 74th percentiles, respectively. Researchers can access high-quality, peer-reviewed articles that contribute significantly to advancing knowledge in the field. With a commitment to fostering open scientific dialogue, Tropical Medicine and Health is not just a journal, but a collaborative space for researchers, students, and practitioners working to improve health outcomes in tropical regions worldwide.
Current HIV/AIDS Reports
Exploring breakthroughs in HIV prevention and care.Current HIV/AIDS Reports, published by Springer, is a distinguished scholarly journal that addresses critical developments in the field of HIV/AIDS research. As a leading publication within the Q1 quartiles for both Infectious Diseases and Virology, it serves as an essential platform for researchers and healthcare providers aiming to advance knowledge and practices related to HIV prevention, treatment, and care. With a commitment to publishing innovative studies, reviews, and clinical guidelines, this journal fosters a comprehensive understanding of the complexities surrounding HIV/AIDS. The journal enjoys a robust reputation, evidenced by its impressive Scopus rankings, including a rank of #69 in Infectious Diseases and #21 in Virology, placing it in the top echelons of its field. With an open-access model, *Current HIV/AIDS Reports* significantly enhances the accessibility of crucial research findings to a global audience, driving progress in HIV/AIDS knowledge and public health.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Fostering innovation in the understanding of infectious agents.ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.
AIDS
Illuminating the Path to Effective TreatmentsAIDS, published by Lippincott Williams & Wilkins, stands as a premier journal within the fields of immunology and infectious diseases, reflecting a distinguished history since its inception in 1987 and offering insights that shape contemporary research and practice. With an impressive impact factor and categorized in the Q1 quartile across critical areas including Immunology, Infectious Diseases, and Immunology and Allergy, the journal showcases high-quality, peer-reviewed articles that consistently contribute to the advancement of knowledge and innovation in the fight against AIDS and related conditions. Researchers and professionals will find its content invaluable, as it brings forth groundbreaking studies, novel therapeutic approaches, and comprehensive reviews that inform both clinical practices and public health policies. Although not an open access journal, it remains a vital resource for those committed to addressing one of the most pressing global health challenges of our time.
JOURNAL OF INFECTIOUS DISEASES
Illuminating the Pathways of Infectious Disease KnowledgeThe JOURNAL OF INFECTIOUS DISEASES, published by OXFORD UNIV PRESS INC, is a leading peer-reviewed journal dedicated to advancing the understanding of infectious diseases through high-quality research. With an impressive impact factor reflecting its prominence in the field—ranking in the Q1 category for both Immunology and Allergy and Infectious Diseases—this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike. Its extensive history, spanning over a century since its inception in 1904, highlights its established authority and commitment to the field. Based in the United Kingdom, the journal covers essential topics from clinical management to epidemiological trends, providing vital insights that inform practice and policy. Although the journal is not open access, it remains accessible to a wide audience, ensuring that critical research continues to drive innovation and best practices in infectious disease management.